GRASPA Treatment for Patients With Acute Myeloblastic Leukemia

Clinical trial NCT01810705 · COMPLETED

Trial details

NCT number: NCT01810705
Sponsor: ERYtech Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2013-02-01
Primary completion: 2017-11-10
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.